Browse the evidence

White adipose tissue (WAT) maintains adipocyte numbers through continuous renewal by committed preadipocytes (hyperplasia) rather than solely through hypertrophy of existing cells, with approximately 10% of adipocytes renewed annually.

Your fat tissue is not static; it is constantly renewing itself. Understanding that new fat cells are generated (hyperplasia) alongside existing ones growing (hypertrophy) helps explain why obesity can be persistent and why weight loss strategies must address both cell size and number.

ASCs exhibit multipotency, differentiating into mesenchymal (adipocytes, osteoblasts, chondrocytes) and non-mesenchymal (neural, endothelial) cell types, though their in vivo functional capacity varies by tissue source and context.

ASCs are versatile and can become many cell types, making them valuable for regenerative medicine. However, their effectiveness in vivo is complex and depends on how they are isolated and used.

In aging and obese men, elevated sex hormone-binding globulin (SHBG) levels are primarily driven by low growth hormone (GH) and insulin-like growth factor 1 (IGF-1) levels, rather than by hyperinsulinism.

If you are older or obese, your low testosterone may be partly due to low Growth Hormone and IGF-1, not just high insulin. Standard weight loss might not fully restore healthy SHBG levels if GH/IGF-1 remains low.

Autophagy is downregulated in the aging heart, and this suppression contributes to cardiac pathology by allowing the accumulation of misfolded proteins and dysfunctional mitochondria.

Maintaining cellular cleanup processes (autophagy) is critical for heart health as you age. While this paper focuses on mechanisms, lifestyle factors known to stimulate autophagy (like caloric restriction or exercise) may help mitigate age-related cardiac decline by preventing the buildup of damaged proteins and mitochondria.

Stimulation of autophagy improves cardiac function in aging hearts by removing accumulated misfolded proteins and dysfunctional mitochondria.

Encouraging autophagy through healthy lifestyle choices may help clear out cellular debris that contributes to heart aging. This suggests that interventions promoting cellular cleanup could be beneficial for long-term heart health.

An earlier age-related onset of obesity (becoming obese before age 20) is independently associated with higher insulin sensitivity and a more favorable lipid profile in obese postmenopausal women.

For obese postmenopausal women, having become obese at a younger age (before 20) may be associated with better insulin sensitivity and lipid profiles compared to those who became obese later in life. This highlights the importance of fat distribution and timing of obesity onset, not just current weight or duration of obesity.

Elevating forearm insulin to high physiologic levels (approx. 157 uU/ml) blocks approximately 74% of skeletal muscle amino acid nitrogen release in postabsorptive humans, primarily by inhibiting the output of branched-chain and aromatic amino acids.

In a fasted state, raising insulin levels significantly stops muscle from breaking down and releasing most amino acids (like leucine and isoleucine) into the blood. However, this effect is not universal; alanine release continues largely unchanged. This suggests insulin's primary job in fasting is to preserve muscle protein by stopping its breakdown, rather than actively building new muscle tissue from scratch.

Doubling basal insulin levels (low-dose infusion) is sufficient to block free fatty acid release from adipose tissue but is often insufficient to block amino acid release from muscle, indicating different sensitivity thresholds for these metabolic pathways.

Low levels of insulin are enough to stop your fat cells from releasing fatty acids, but they are often not enough to stop your muscles from releasing amino acids. To significantly reduce muscle protein breakdown, you likely need higher insulin levels or other strategies, as low-level insulin elevation primarily targets fat metabolism.

Skeletal muscle-specific ablation of the core clock gene Bmal1 causes impaired insulin-stimulated glucose uptake and reduced glucose oxidation, primarily through reduced protein levels of GLUT4 and TBC1D1 and altered pyruvate dehydrogenase (PDH) activity.

Your muscles have an internal clock that prepares them to process glucose efficiently during your active/feeding phases. Disrupting this rhythm (e.g., through irregular sleep or eating times) may impair your muscles' ability to take up glucose in response to insulin, even if you are not overweight. Maintaining consistent sleep and meal timing supports optimal muscle insulin sensitivity.

Defects in DNA repair pathways (specifically NER and BER) and the resulting accumulation of DNA damage are causally linked to premature aging syndromes and neurodegenerative diseases, whereas enhanced DNA repair capacity is associated with increased longevity.

Maintaining genomic integrity is critical for healthy aging. While you cannot directly 'dose' DNA repair, supporting cellular health through lifestyle factors that minimize oxidative stress and support metabolic function may help preserve DNA repair capacity. Avoiding excessive genotoxic stressors (like smoking or extreme UV exposure) is a practical application of this mechanism.

Intensive lifestyle interventions (diet, exercise, or combined) fail to maintain long-term weight loss or behavioral changes beyond 6 months in overweight individuals with a family history of diabetes, resulting in no sustained difference in diabetes risk between treatment groups at 2 years.

Standard lifestyle interventions (diet and exercise programs) often fail to maintain weight loss or health benefits beyond 6 months for high-risk individuals. While initial weight loss is beneficial, the lack of long-term maintenance means that standard programs may not be sufficient for preventing diabetes over 2 years. More effective strategies to sustain engagement are needed.

Central fat distribution (waist circumference and waist-to-hip ratio) is an independent negative predictor of serum adiponectin levels, stronger than overall adiposity (BMI or total fat mass).

If you want to support healthy adiponectin levels, focus on reducing abdominal fat (waist circumference) rather than just total body weight. Central fat is a stronger determinant of low adiponectin than overall obesity.

Acute fasting (48 hours) and leptin administration (physiological or pharmacological doses) do not alter serum adiponectin levels in healthy humans.

Short-term fasting (48 hours) or taking leptin supplements will not change your blood levels of adiponectin. Do not expect these interventions to boost adiponectin directly.

Serum estradiol is an independent negative predictor of serum adiponectin levels, explaining higher adiponectin in postmenopausal women compared to premenopausal women.

Lower estrogen levels (as seen in menopause) are associated with higher adiponectin. This is an independent factor from body fat.

The 'double burden of malnutrition'—coexistence of stunting in children and overweight/obesity in mothers within the same household or community—is a significant feature of the nutrition transition in Sub-Saharan Africa.

Public health interventions in SSA must address both undernutrition in children and overnutrition in adults simultaneously, as they often coexist in the same households due to shared socioeconomic and environmental factors.

Adipose tissue functions as an active immunological organ during obesity, where expansion triggers chronic low-grade inflammation via immune cell infiltration and DAMP sensing, leading to systemic insulin resistance and metabolic syndrome.

Obesity is not just about storing excess calories; it triggers an immune response in fat tissue that causes insulin resistance. This means that simply losing weight without addressing the underlying inflammation might not fully restore metabolic health, and long-term weight maintenance is crucial to resolving this immune activation.

Macrophage polarization from anti-inflammatory M2 to pro-inflammatory M1 phenotypes in adipose tissue is a key driver of insulin resistance, driven by the sensing of metabolic danger signals (DAMPs) like free fatty acids and uric acid.

The type of immune cells in your fat matters. In obesity, fat tissue fills with pro-inflammatory M1 macrophages that release chemicals blocking insulin action. Weight loss can help restore these cells to a healthier, anti-inflammatory state, but this process may take time and requires sustained weight stability.

Birth weight is strongly predictive of later lean mass but has a much weaker association with later fatness, contradicting the historical view that large babies simply become obese adults.

Don't assume a large baby will inevitably be an obese adult. Birth weight is a better predictor of future muscle mass (lean mass) than fat mass. Focus on healthy postnatal growth rather than worrying solely about birth size for obesity risk.

Infant weight gain predicts lean mass in developing countries but predicts fat mass and obesity in industrialized populations.

In industrialized nations, rapid infant weight gain is a risk factor for obesity. In developing countries, it may help build muscle mass. Public health advice should be tailored to the local context and genetic background.

Higher genetically predicted body mass index (BMI) and fat mass index causally increase the risk of aortic valve stenosis, heart failure, deep vein thrombosis, arterial hypertension, peripheral artery disease, coronary artery disease, atrial fibrillation, and pulmonary embolism.

Maintaining a healthy body weight, specifically by reducing fat mass, is a critical step in preventing a wide range of cardiovascular diseases, including heart failure, coronary artery disease, and aortic valve stenosis. Genetic predisposition to higher BMI increases this risk, suggesting that lifestyle interventions aimed at weight loss and fat reduction are essential for cardiovascular health, regardless of current symptoms.

Higher genetically predicted fat mass index is strongly associated with an increased risk of aortic valve stenosis, with the strongest magnitude of association observed among all cardiovascular conditions studied.

Reducing fat mass is particularly important for preventing aortic valve stenosis, as it shows the strongest association among all cardiovascular conditions studied. Focus on fat loss strategies, such as caloric deficit and aerobic exercise, to specifically target fat mass reduction for better heart valve health.

SGLT2 inhibitors reduce major adverse cardiovascular events (MACE) by 11% and heart failure hospitalization by 23% in patients with type 2 diabetes and established cardiovascular disease.

If you have Type 2 Diabetes and heart disease or heart failure, ask your doctor about SGLT2 inhibitors (like empagliflozin or dapagliflozin). These drugs not only help control blood sugar but have been proven to significantly reduce the risk of heart attacks, strokes, and hospitalizations for heart failure, regardless of your current blood sugar levels.

High-fat diet consumption triggers rapid hypothalamic inflammation (via TLR4/JNK/NF-κB pathways) that causes central insulin and leptin resistance, uncoupling energy balance and driving obesity.

Focus on reducing saturated fats (like palmitic acid) in your diet, as they directly trigger brain inflammation that blocks satiety hormones. This isn't just about calories; it's about protecting your brain's ability to regulate hunger and metabolism.

Saturated fatty acids (SFAs) like palmitate cross the blood-brain barrier and accumulate in the hypothalamus, directly causing insulin and leptin resistance via TLR4 and JNK activation.

Limit intake of saturated fats (found in fatty meats, butter, cheese) to prevent them from entering the brain and blocking weight-regulating hormones.